Dr. Michael L. Pearl, MD

Dr. Pearl practices at University Associates in Obstetrics & Gynecology, University Faculty P in Stony Brook, New York.

Dr. Pearl's NPI, 1043219512, was assigned on July 18, 2005. Dr. Pearl graduated from University of California, San Francisco School of Medicine in 1986. Dr. Pearl holds New Hampshire license 23918.

Dr. Pearl's primary practice is University Associates in Obstetrics & Gynecology, University Faculty P, at 3 Edmund D Pellegrino Rd, Stony Brook, NY 11794 in Suffolk County. The practice phone is (631) 444-2731.

Dr. Pearl's primary practice is University Associates in Obstetrics & Gynecology, University Faculty P in Stony Brook, New York. Dr. Pearl is also affiliated with Dartmouth Hitchcock Medical Center. The medical group on file is Dartmouth Hitchcock Medical Center. Dmand AI also links Dr. Pearl to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pearl practices. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Pearl's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dmand AI has Dr. Pearl's licenses on file in 2 states: New Hampshire and New York.

CMS data shows 220 Medicare services from Dr. Pearl across 4 procedure codes in 2024, all of them office visits, for 168 Medicare patients. Medicare paid $17,873 for them. Every service was in an office.

CMS counts 168 Medicare patients who saw Dr. Pearl in 2024. The largest group is 65 to 74, with 82 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Pearl's median patient age at 66, with 99% women.

In 2024, Dr. Pearl wrote 17 Medicare Part D claims for 11 patients. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $6,510 in total drug cost. In 2021, CMS named 11 claims across 1 drug.

Dr. Pearl accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pearl as offering telehealth.

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 29 papers to Dr. Pearl, published from 2013 to 2023. 2017 was the busiest year, with 8. The most frequent topics are Endometrial Neoplasms, Carcinoma, Endometrioid and Antineoplastic Combined Chemotherapy Protocols. Dr. Pearl has published most often in Gynecol Oncol. Dr. Pearl's most frequent co-authors are William Thomas Creasman, MD, Paul Andrew Disilvestro, MD and Rahel G. Ghebre, MD.

CMS Open Payments shows 6 general payments to Dr. Pearl from 5 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $236.

Dr. Pearl graduated from University of California, San Francisco School of Medicine in 1986.